good lesson to continue in being LT focused
Helping foster a breakthrough - leapfrog - technology here - we’ve arrived at the pointy end of regulatory approvals, never easy for an emerging technology.
The FDA steel man argument is one of off targets - and extra data points around PK and bio distribution is the right approach as the CPP-PMO combo are rare as a hen’s teeth thus far.
good lesson to continue in being LT focusedHelping foster a...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.020(1.77%) |
Mkt cap ! $664.9M | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.18 | $1.11 | $172.3K | 151.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 592 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 4211 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |